Atara Biotherapeutics, Inc.
Atara develops off-the-shelf allogeneic T-cell therapies for cancers and autoimmune conditions.
424B4Sep 18Latest SEC filing
Sep 16Latest story
August 2026
Sign inSign inAtara develops off-the-shelf allogeneic T-cell therapies for cancers and autoimmune conditions.